We are conducting research on human-induced pluripotent stem cells (hiPSCs) and the most advanced gene-editing technologies.

Our goal is to contribute our findings to the broader scientific community, helping accelerate the development of treatments for a wide range of rare diseases caused by single-gene mutations.